Antioxidant Supplementation Effects on Low-Density Lipoprotein Oxidation for Individuals with Type 2 Diabetes Mellitus

REFERENCES

• Bierman EL: Atherogenesis in diabetes. Arterioscl Thromb 12: 647–656, 1992.
   PubMed Web of Science ®Google Scholar
• Ginsberg HN: Lipoprotein physiology in nondiabetic and diabetic states: Relationship to atherogenesis. Diabetes Care 14: 839–855, 1991.
   PubMedGoogle Scholar
• Giugliano D, Ceriello A, Paolisso G: Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress. Metabolism 44: 363–368, 1995.
   PubMed Web of Science ®Google Scholar
• Pi-Sunyer FX: Medical hazards of obesity. Ann Intern Med 119: 655–660, 1993.
   PubMed Web of Science ®Google Scholar
• Chisolm GM, Irwin KC, Penn MS: Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 41: 61–66, 1992.
   PubMedGoogle Scholar
• Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41: 67–73, 1992.
   PubMed Web of Science ®Google Scholar
• Hunt JV, Wolff SP: Oxidative glycation and free radical production: a causal mechanism of diabetic complications. Free Rad Res Comms 12–13: 115–123, 1991.
   PubMedGoogle Scholar
• Sobenin IA, Tertov VV, Orekov AN: Atherogenic modified LDL in diabetes. Diabetes 45: S35–S39, 1996.
   Google Scholar
• Bowie A, Owens D, Collins P, Johnson A, Tomkin GH: Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? Atherosclerosis 102: 63–67, 1993.
   PubMed Web of Science ®Google Scholar
• Jialal I, Devaraj S: The role of oxidized low density lipoprotein in atherogenesis. J Nutr 126: 1053S–1057S, 1996.
   PubMed Web of Science ®Google Scholar
• Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM: The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 16: 831–842, 1996.
   PubMed Web of Science ®Google Scholar
• Gey KF: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53: 326S–334S, 1991.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett W: Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450–1456, 1993.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC: Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328: 1444–1449, 1993.
   PubMed Web of Science ®Google Scholar
• Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P, Hamsten A: Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 63: 377–385, 1996.
   PubMedGoogle Scholar
• Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Servanian A, Johnson R, Azen SP: Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273: 1849–1854, 1995.
   PubMed Web of Science ®Google Scholar
• Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ: Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet 347: 781–785, 1996.
   PubMed Web of Science ®Google Scholar
• Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H: Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32: 1325–1332, 1991.
   PubMed Web of Science ®Google Scholar
• Jialal I, Fuller CJ, Huet BA: The effect of alpha-tocopherol supplementation on LDL oxidation. Arterioscler Thromb Vasc Biol 15: 190–198, 1995.
   PubMed Web of Science ®Google Scholar
• Reaven PD, Barnett J, Herold DA, Edelman S: Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18: 807–816, 1995.
   PubMed Web of Science ®Google Scholar
• Fuller CJ, Chandalia M, Garg A, Grundy SM, Jialal I: RRR-a-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidation susceptibility but not protein glycation in patients with diabetes mellitus. Am J Clin Nutr 63: 753–759, 1996.
   PubMedGoogle Scholar
• Esterbauer H, Ramos P: Chemistry and pathophysiology of oxidation of LDL. Rev Physiol Biochem Pharmacol 127: 31–64, 1995.
   Web of Science ®Google Scholar
• Jialal I, Grundy SM: Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 87: 597–601, 1991.
   PubMed Web of Science ®Google Scholar
• Bridges RB, Anderson JW, Saxe SR, Gregory K, Bridges SR: Periodontal status of diabetic and non-diabetic men: Effect of smoking, glycemic control, and socioeconomic factors. J Periodontol 67: 1185–1192, 1996.
   PubMed Web of Science ®Google Scholar
• Kadish AH, Little RI, Sternberg JC: A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131, 1968.
   Web of Science ®Google Scholar
• Klenk DC, Hermanson GT, Krohn RI, Fujimoto EK, Mallia AK, Smith PK, England JD, Wiedmeyer HM, Little RR, Goldstein DE: Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem 28: 2088–2094, 1982.
   PubMed Web of Science ®Google Scholar
• Anderson JW, Gustafson NJ: Hypocholeterolemic effects of oat and bean products. Am J Clin Nutr 48: 749–753, 1988.
   PubMed Web of Science ®Google Scholar
• Hatam LJ, Kayden HJ: A high performance liquid chromatographic method for the determination of tocopherol in plasma and cellulose elements of the blood. J Lipid Res 20: 639–645, 1979.
   PubMed Web of Science ®Google Scholar
• Bieri JG, Brown ED, Smith JC: Determination of individual carotenoids in human plasma by high performance liquid chromatography. J Liq Chromatogr 7: 2611–2630, 1985.
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randal BJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265–275, 1951.
   PubMed Web of Science ®Google Scholar
• Strachan AF, de Beer FC, Van der Westhuyzen DR, Coetzee GA: Identification of three isoforms pattern of human serum amyloid A protein. Biochem J 250: 203–207, 1988.
   PubMedGoogle Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms 6: 67–75, 1989.
   PubMed Web of Science ®Google Scholar
• Niki E: Free radical initiators as source of water- or lipid-soluble peroxyl radicals. Methods Enzymol 186: 100–108, 1990.
   PubMed Web of Science ®Google Scholar
• Hazell LJ, Stocker R: Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 290: 165–172, 1993.
   PubMed Web of Science ®Google Scholar
• Kosugi K, Kikugawa K: Thiobarbituric acid reaction of aldehydes and oxidized lipids in glacial acetic acid. Lipids 20: 195–199, 1985.
   PubMed Web of Science ®Google Scholar
• Steinbrecher UP: Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J Biol Chem 262: 3603–3608, 1987.
   PubMed Web of Science ®Google Scholar
• Habeeb AFSA: Determination of free amino groups in protein by trinitrobenzene sulfonic acid. Anal Biochem 14: 328–336, 1966.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, Bamshad B, Esterson M, Fogelman AM: Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest 85: 1260–1266, 1990.
   PubMed Web of Science ®Google Scholar
• Stephan ZF, Yurachek EC: Rapid fluorometric assay of LDL receptor activity by Dil-labeled LDL. J Lipid Res 34: 325–330, 1993.
   PubMedGoogle Scholar
• Rabini RA, Ferretti G, Galassi R, Taus M, Curatola G, Tangorra A, Fumelli P, Mazzanti L: Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients. Clin Biochem 27: 381–385, 1994.
   PubMedGoogle Scholar
• Princen HMG, van Poppel G, Vogelezang C, Buytenhek R, Kok FJ: Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking. Arterioscler Thromb 12: 554–562, 1992.
   PubMed Web of Science ®Google Scholar
• Jialal I, Grundy SM: Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 88: 2780–2786, 1993.
   PubMed Web of Science ®Google Scholar
• Abbey M, Nestel PJ, Baghurst PA: Antioxidant vitamins and low-density-lipoprotein oxidation. Am J Clin Nutr 58: 525–532, 1993.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ: Vitamin E reduction of protein glycosylation in diabetes. Diabetes Care 14: 68–72, 1991.
   PubMed Web of Science ®Google Scholar
• Jain SK, McVie R, Jaramillo JJ, Palmer M, Smith T, Meachum ZD, Little RL: The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 31: S87–S90, 1996.
   PubMed Web of Science ®Google Scholar
• Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF: Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337: 1–5, 1991.
   PubMed Web of Science ®Google Scholar
• Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, et al: Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 342: 1379–1384, 1993.
   PubMed Web of Science ®Google Scholar
• Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156–1162, 1996.
   PubMed Web of Science ®Google Scholar
• Jha P, Flather M, Lonn E, Farkouh M, Yusuf S: The antioxidant vitamins and cardiovascular disease. Ann Intern Med 123: 860–872, 1995.
   PubMed Web of Science ®Google Scholar
• Lyons TJ: Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 71: 26B–31B, 1993.
   Google Scholar
• Steinbrecher UP, Witztum JL: Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33: 130–134, 1984.
   PubMed Web of Science ®Google Scholar
• Li D, Devaraj S, Fuller C, Bucala R, Jialal I: Effect of a-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. J Lipid Res 37: 1978–1986, 1996.
   PubMed Web of Science ®Google Scholar
• Gisinger C, Jeremy J, Speiser P, Mikhailidis D, Dandona P, Schernthaner G: Effect of vitamin E supplementation on platelet thromboxane A2 production in type I diabetic patients. Diabetes 37: 1260–1264, 1988.
   PubMed Web of Science ®Google Scholar
• Gowri MS, Van der Westhuyzen DR, Bridges SR, Anderson JW: Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may be due to its abnormal composition. Atheroscler Thromb Vasc Biol, in press, 1999.
   Google Scholar